APA Alıntı

Wu, X., Xu, R., Ouyang, Z., Qian, C., Shen, Y., Wu, X., . . . Sun, Y. (2013). Beauvericin Ameliorates Experimental Colitis by Inhibiting Activated T Cells via Downregulation of the PI3K/Akt Signaling Pathway. Public Library of Science.

Chicago Stili Alıntı

Wu, Xue-Feng, Rui Xu, Zi-Jun Ouyang, Cheng Qian, Yan Shen, Xu-Dong Wu, Yan-Hong Gu, Qiang Xu, ve Yang Sun. Beauvericin Ameliorates Experimental Colitis By Inhibiting Activated T Cells Via Downregulation of the PI3K/Akt Signaling Pathway. Public Library of Science, 2013.

MLA Alıntı

Wu, Xue-Feng, et al. Beauvericin Ameliorates Experimental Colitis By Inhibiting Activated T Cells Via Downregulation of the PI3K/Akt Signaling Pathway. Public Library of Science, 2013.